Clinical & Translational Insights from Microbiome Modulation Trials at MD Anderson
Time: 1:30 pm
day: Conference Day One, Track One, PM
Details:
- Exploring key clinical and translational insights gained from a variety of microbiome modulation trials at MD Anderson, highlighting their impact on cancer treatment and patient outcomes
- Discussing the major findings from these trials, including how microbiome composition influences therapy response and potential strategies for leveraging microbial interventions
- Outlining the next steps in research and clinical application, focusing on the challenges and opportunities in translating microbiome science into precision cancer care
